Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small-Molecule PROTACs for Cancer Immunotherapy. | Molecules | 2022 | 36080223 | PubTator, text mining | PubMed |
| CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma. | Cancers (Basel) | 2022 | 36077711 | PubTator, text mining | PubMed |
| Multiple Myeloma Therapy: Emerging Trends and Challenges. | Cancers (Basel) | 2022 | 36077618 | PubTator, text mining | PubMed |
| A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors. | Int J Mol Sci | 2022 | 36077415 | PubTator, text mining | PubMed |
| Target protein localization and its impact on PROTAC-mediated degradation. | Cell Chem Biol | 2022 | 36075213 | PubTator, text mining | PubMed |
| Exploring the target scope of KEAP1 E3 ligase-based PROTACs. | Cell Chem Biol | 2022 | 36070758 | PubTator, text mining | PubMed |
| Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs). | Chem Commun (Camb) | 2022 | 36065962 | PubTator, text mining | PubMed |
| Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity? | Front Oncol | 2022 | 36059621 | PubTator, text mining | PubMed |
| Transcriptional profiles define drug refractory disease in myeloma. | EJHaem | 2022 | 36051067 | PubTator, text mining | PubMed |
| Recent advancements in the discovery of cereblon-based protease-targeted chimeras with potential for therapeutic intervention. | Future Med Chem | 2022 | 36047364 | PubTator, text mining | PubMed |
| Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome. | Intern Med | 2022 | 36047093 | PubTator, text mining | PubMed |
| Myeloid cell leukemia-1: a formidable barrier to anticancer therapeutics and the quest of targeting it. | Explor Target Antitumor Ther | 2022 | 36045907 | PubTator, text mining | PubMed |
| Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation. | Elife | 2022 | 36043466 | PubTator, text mining | PubMed |
| PROTACs bearing piperazine-containing linkers: what effect on their protonation state? | RSC Adv | 2022 | 36043064 | PubTator, text mining | PubMed |
| The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells. | Sci Signal | 2022 | 36041010 | PubTator, text mining | PubMed |
| Early administration of lenalidomide after allogeneic hematopoietic stem cell transplantation suppresses graft-versus-host disease by inhibiting T-cell migration to the gastrointestinal tract. | Immun Inflamm Dis | 2022 | 36039651 | PubTator, text mining | PubMed |
| Clinical and mechanistic insights into the roles of DDX41 in haematological malignancies. | FEBS Lett | 2022 | 36036093 | PubTator, text mining | PubMed |
| Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer. | Front Pharmacol | 2022 | 36034876 | PubTator, text mining | PubMed |
| UDP-Glucose: A Cereblon-Dependent Glucokinase Protein Degrader. | Int J Mol Sci | 2022 | 36012359 | PubTator, text mining | PubMed |
| TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer. | Cancers (Basel) | 2022 | 36011046 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=54